Abstract
Many factors, including lower risk of GVHD, rapid availability of 4/6–6/6 matched cord blood (CB) units and incremental gains in the outcomes, have led to an increasing use of CB transplantation (CBT) to treat many patients who lack fully matched adult BM donors. A large electronically searchable worldwide inventory of publicly banked CB units allows for quicker donor identification and selection. In this review, we examine the current status and cumulative experience of related and unrelated donor CBT for the treatment of non-malignant diseases, including hemoglobinopathies, BM failure syndromes, primary immunodeficiency diseases (PIDs) and inherited metabolic disorders (IMDs), and conclude that CBT offers a promising and effective therapy for these diseases. Future strategies to facilitate earlier diagnosis and to decrease transplant-related risks should further improve the short- and long-term outcomes. Every effort should be made to perform transplantation early in the course of disease before extensive damage to various tissues and organs ensues.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007; 369: 1947–1954.
Kurtzberg J, Prasad VK, Carter SL, Wagner JE, Baxter-Lowe LA, Wall D et al. Results of the cord blood transplantation study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008; 112: 4318–4327.
Martin PL, Carter SL, Kernan NA, Sahdev I, Wall D, Pietryga D et al. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 2006; 12: 184–194.
Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 2008; 112: 2979–2989.
Rocha V, Wagner Jr JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342: 1846–1854.
Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962–2971.
Rocha V, Sanz G, Gluckman E . Umbilical cord blood transplantation. Curr Opin Hemat 2004; 11: 375–385.
Rocha V, Gluckman E . Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant 2006; 12: 34–41.
Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565–1577.
Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.
Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174–1178.
Kurtzberg J, Graham M, Casey J, Olson J, Stevens CE, Rubinstein P . The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells 1994; 20: 275–283.
Barker JN, Davies SM, Defor T, Ramsay NK, Weisdorf DJ, Wagner JE . Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957–2961.
Barker JN, Wagner JE . Umbilical cord blood transplantation: current practice and future innovations. Crit Rev Oncol Hematol 2003; 48: 35–43.
Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 1993; 329: 840–844.
Boulad F, Giardina P, Gillio A, Kernan N, Small T, Brochstein J et al. Bone marrow transplantation for homozygous beta-thalassemia. The Memorial Sloan-Kettering Cancer Center experience. Ann N Y Acad Sci 1998; 850: 498–502.
Chandy M, Balasubramanian P, Ramachandran SV, Mathews V, George B, Dennison D et al. Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia--the role of busulfan pharmacokinetics in determining outcome. Bone Marrow Transplant 2005; 36: 839–845.
Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990; 322: 417–421.
Lucarelli G, Andreani M, Angelucci E . The cure of thalassemia by bone marrow transplantation. Blood Rev 2002; 16: 81–85.
Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, Bertrand Y et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007; 110: 2749–2756.
Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998; 22: 1–6.
Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996; 335: 369–376.
Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000; 95: 1918–1924.
Bhatia M, Walters MC . Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. [Review] [57 references]. Bone Marrow Transplant 2008; 41: 109–117.
Issaragrisil S, Visuthisakchai S, Suvatte V, Tanphaichitr VS, Chandanayingyong D, Schreiner T et al. Brief report: transplantation of cord-blood stem cells into a patient with severe thalassemia. N Engl J Med 1995; 332: 367–369.
Reed W, Walters M, Lubin BH . Collection of sibling donor cord blood for children with thalassemia. J Pediatr Hematol Oncol 2000; 22: 602–604.
Walters MC, Quirolo L, Trachtenberg ET, Edwards S, Hale L, Lee J et al. Sibling donor cord blood transplantation for thalassemia major: experience of the sibling donor cord blood program. Ann N Y Acad Sci 2005; 1054: 206–213.
Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101: 2137–2143.
Fang J, Huang S, Chen C, Zhou D, Li CK, Li Y et al. Umbilical cord blood transplantation in Chinese children with beta-thalassemia. J Pediatr Hematol Oncol 2004; 26: 185–189.
Brichard B, Vermylen C, Ninane J, Cornu G . Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia. J Pediatr 1996; 128: 241–243.
Gore L, Lane PA, Quinones RR, Giller RH . Successful cord blood transplantation for sickle cell anemia from a sibling who is human leukocyte antigen-identical: implications for comprehensive care. J Pediatr Hematol Oncol 2000; 22: 437–440.
Hall JG, Martin PL, Wood S, Kurtzberg J . Unrelated umbilical cord blood transplantation for an infant with beta-thalassemia major. J Pediatr Hematol Oncol 2004; 26: 382–385.
Adamkiewicz TV, Szabolcs P, Haight A, Baker KS, Staba S, Kedar A et al. Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience. Pediatr Transplant 2007; 11: 641–644.
Fang J, Huang S, Chen C, Zhou D . Unrelated umbilical cord blood transplant for beta-thalassemia major. J Trop Pediatr 2003; 49: 71–73.
Jaing TH, Hung IJ, Yang CP, Lin TY, Chow R, Hsieh SI . Successful unrelated cord blood transplantation in a child with beta-thalassemia major. J Trop Pediatr 2005; 51: 122–124.
Jaing TH, Yang CP, Hung IJ, Chen SH, Sun CF, Chow R . Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia. Bone Marrow Transplant 2007; 40: 307–311.
Mazur M, Kurtzberg J, Halperin E, Ciocci G, Szabolcs P . Transplantation of a child with sickle cell anemia with an unrelated cord blood unit after reduced intensity conditioning. J Pediatr Hematol Oncol 2006; 28: 840–844.
Vanichsetakul P, Wacharaprechanont T, Charoen R, Seksarn P, Kupatawintu P . Umbilical cord blood transplantation in children with beta-thalassemia diseases. J Med Assoc Thai 2004; 87: S62–S67.
Tan PH, Hwang WY, Goh YT, Tan PL, Koh LP, Tan CH et al. Unrelated peripheral blood and cord blood hematopoietic stem cell transplants for thalassemia major. Am J Hematol 2004; 75: 209–212.
Jaing TH, Hung IJ, Yang CP, Chen SH, Sun CF, Chow R . Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major. Biology of Blood and Marrow Transplantation 2005; 11: 349–353.
Jaing TH, Wang B, Gjertson D, Petz L, Chow R . Unrelated cord blood transplantation (UCBT) of 30 consecutive patients with transfusion-dependent [beta]-thalassemia from a single center. Biol Blood Marrow Transplant 2009; 15: 24–25.
Bhatia M, Morris E, Moore V, Tallamy B, George D, Garvin JH et al. A pilot study of reduced intensity conditioning (RI) with busulfan (Bu), fludarabine (Flu), and alemtuzumab followed by allogeneic stem cell transplantation (alloSCT) to induce sustained mixed donor chimerism in patients with symptomatic sickle cell disease (SCD). Biol Blood Marrow Transplant 2009; 15: 23–24.
Shenoy S, Grossman WJ, DiPersio J, Yu LC, Wilson D, Barnes YJ et al. A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant 2005; 35: 345–352.
Buckley RH, Schiff SE, Schiff RI, Roberts JL, Markert ML, Peters W et al. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. Semin Hematol 1993; 30: 92–101.
Cairo MS, Rocha V, Gluckman E, Hale G, Wagner J . Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors. Biol Blood Marrow Transplant 2008; 14: 44–53.
Parikh SH, Szabolcs P, Prasad VK, Lakshminarayanan S, Martin PL, Driscoll TA et al. Correction of chronic granulomatous disease after second unrelated-donor umbilical cord blood transplantation. Pediatr Blood Cancer 2007; 49: 982–984.
Sun JM, Driscoll T, Prasad VK, Parikh S, Szabolcs P, Kurtzberg J et al. Unrelated umbilical cord blood transplantation is an effective therapy for Wiskott-Aldrich syndrome. Biol Blood Marrow Transplant 2009; 15: 76.
Gluckman E, Rocha V, Ionescu I, Bierings M, Harris RE, Wagner J et al. Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007; 13: 1073–1082.
Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007; 109: 2256–2262.
Neudorf SM, Blatt J, Corey S, Koehler M, Wollman M, Rosner G et al. Graft failure after an umbilical cord blood transplant in a patient with severe aplastic anemia. Blood 1995; 85: 2991–2992.
Yoshimi A, Kojima S, Taniguchi S, Hara J, Matsui T, Takahashi Y et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant 2008; 14: 1057–1063.
Chan KW, McDonald L, Lim D, Grimley MS, Grayson G, Wall DA . Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia. Bone Marrow Transplant 2008; 42: 589–595.
Mao P, Zhu Z, Wang H, Wang S, Mo W, Ying Y et al. Sustained and stable hematopoietic donor-recipient mixed chimerism after unrelated cord blood transplantation for adult patients with severe aplastic anemia. Eur J Haematol 2005; 75: 430–435.
Ohga S, Ichino K, Goto K, Hattori S, Nomura A, Takada H et al. Unrelated donor cord blood transplantation for childhood severe aplastic anemia after a modified conditioning. Pediatr Transplant 2006; 10: 497–500.
Krivit W . Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. [Review] [55 references]. Springer Semin Immunopathol 2004; 26: 119–132.
Muenzer J, Fisher A . Advances in the treatment of mucopolysaccharidosis type I. [comment]. N Engl J Med 2004; 350: 1932–1934.
Fratantoni JC, Hall CW, Neufeld EF . Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. Science 1968; 162: 570–572.
Neufeld EF, Fratantoni JC . Inborn errors of mucopolysaccharide metabolism. Science 1970; 169: 141–146.
Chua SJ, Bielecki R, Wong CJ, Yamanaka N, Rogers IM, Casper RF . Neural progenitors, neurons and oligodendrocytes from human umbilical cord blood cells in a serum-free, feeder-free cell culture. Biochem Biophys Res Commun 2009; 379: 217–221.
Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004; 200: 123–135.
Tracy E, Aldrink J, Panosian J, Beam D, Thacker J, Reese M et al. Isolation of oligodendrocyte-like cells from human umbilical cord blood. Cytotherapy 2008; 10: 518–525.
Hess DA, Craft TP, Wirthlin L, Hohm S, Zhou P, Eades WC et al. Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity. Stem Cells 2008; 26: 611–620.
Yagi T, Matsuda J, Tominaga K, Suzuki K, Suzuki K . Hematopoietic cell transplantation ameliorates clinical phenotype and progression of the CNS pathology in the mouse model of late onset Krabbe disease. J Neuropathol Exp Neurol 2005; 64: 565–575.
Kurtzberg J, Kosaras B, Stephens C, Snyder EY . Umbilical cord blood cells engraft and differentiate in neural tissues after human transplantation. Biol Blood Marrow Transplant 2003; 9: 128–129.
Boelens JJ, Wynn RF, O'Meara A, Veys P, Bertrand Y, Souillet G et al. Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 2007; 40: 225–233.
Tokimasa S, Ohta H, Takizawa S, Kusuki S, Hashii Y, Sakai N et al. Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: single-institute experience. Pediatr Transplant 2008; 12: 672–676.
Beam D, Poe MD, Provenzale JM, Szabolcs P, Martin PL, Prasad V et al. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. Biol Blood Marrow Transplant 2007; 13: 665–674.
Escolar ML, Poe MD, Provenzale JM, Richards KC, Allison J, Wood S et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease.[see comment]. N Engl J Med 2005; 352: 2069–2081.
Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.[see comment]. N Engl J Med 2004; 350: 1960–1969.
Hansen MD, Filipovich AH, Davies SM, Mehta P, Bleesing J, Jodele S et al. Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen. Bone Marrow Transplant 2008; 41: 349–353.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prasad, V., Kurtzberg, J. Umbilical cord blood transplantation for non-malignant diseases. Bone Marrow Transplant 44, 643–651 (2009). https://doi.org/10.1038/bmt.2009.290
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.290
Keywords
This article is cited by
-
Cord blood research, banking, and transplantation: achievements, challenges, and perspectives
Bone Marrow Transplantation (2020)
-
Mesenchymal stem/stromal cells—a key mediator for regeneration after perinatal morbidity?
Molecular and Cellular Pediatrics (2016)
-
TNF-alpha and Notch signaling regulates the expression of HOXB4 and GATA3 during early T lymphopoiesis
In Vitro Cellular & Developmental Biology - Animal (2016)
-
Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload
Stem Cell Research & Therapy (2015)
-
Stem cell therapies and regenerative medicine in China
Science China Life Sciences (2014)